Insider Selling: Hinge Health (NYSE:HNGE) CEO Sells $410,820.00 in Stock

Hinge Health Inc. (NYSE:HNGE) CEO Daniel Perez sold 4,100 shares of Hinge Health stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $100.20, for a total transaction of $410,820.00. Following the transaction, the chief executive officer owned 4,100 shares of the company’s stock, valued at $410,820. The trade was a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Daniel Antonio Perez also recently made the following trade(s):

• On Thursday, September 10th, Daniel Perez sold 150,000 shares of Hinge Health stock. The stock was sold at an average price of $89.44, for a total value of $13,416,000.00.
• On Thursday, September 10th, Daniel Perez sold 100,000 shares of Hinge Health stock. The stock was sold at an average price of $89.45, for a total value of $8,945,000.00.

Hinge Health Stock Up 4.9%

HNGE stock opened at $102.82 on Friday. The business has a 50 day moving average of $91.24 and a 200 day moving average of $71.21. The firm has a market cap of $8.30 billion, a PE ratio of 80.33 and a beta of 1.37. Hinge Health Inc. has a twelve month low of $30.08 and a twelve month high of $103.28.

Hinge Health (NYSE:HNGE) last released its earnings results on Tuesday, August 4th. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.31. Hinge Health had a return on equity of 51.60% and a net margin of 15.15%. The firm had revenue of $212.82 million for the quarter. During the same period in the prior year, the company posted $0.59 earnings per share. The company’s revenue was up 53.0% on a year-over-year basis. On average, research analysts expect that Hinge Health Inc. will post 1.25 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently commented on HNGE. Citigroup reissued an “outperform” rating on shares of Hinge Health in a research report on Monday, July 27th. Needham & Company LLC lifted their target price on shares of Hinge Health from $97.00 to $115.00 and gave the stock a “buy” rating in a report on Wednesday, September 30th. Canaccord Genuity Group set a $105.00 target price on shares of Hinge Health in a research note on Wednesday, August 5th. Bank of America began coverage on shares of Hinge Health in a research note on Tuesday, September 29th. They issued a “buy” rating and a $110.00 target price on the stock. Finally, Citizens Jmp increased their price target on shares of Hinge Health from $96.00 to $107.00 and gave the company a “market outperform” rating in a report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $105.33.

Institutional Trading of Hinge Health

A number of institutional investors have recently made changes to their positions in HNGE. IFP Advisors Inc raised its holdings in shares of Hinge Health by 140.0% during the second quarter. IFP Advisors Inc now owns 324 shares of the company’s stock valued at $27,000 after purchasing an additional 189 shares during the last quarter. Janney Montgomery Scott LLC raised its stake in Hinge Health by 3.3% during the 1st quarter. Janney Montgomery Scott LLC now owns 9,400 shares of the company’s stock valued at $362,000 after buying an additional 300 shares during the last quarter. Nykredit A S purchased a new stake in Hinge Health during the 2nd quarter valued at $29,000. Lazard Asset Management LLC lifted its holdings in shares of Hinge Health by 0.6% during the 1st quarter. Lazard Asset Management LLC now owns 63,705 shares of the company’s stock valued at $2,456,000 after buying an additional 386 shares during the period. Finally, Caitong International Asset Management Co. Ltd bought a new position in shares of Hinge Health during the 4th quarter valued at $26,000.

Hinge Health Company Profile

Hinge Health, Inc is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care designed to help members manage pain, improve mobility and avoid or delay more invasive treatments.

Its platform combines a mobile application, motion-sensing technology, personalized exercise therapy, education and support from a care team that may include clinical specialists. Hinge Health offers programs for conditions such as chronic back pain, knee pain and other common MSK issues, with services generally provided through employers, health plans and other healthcare organizations.

Hinge Health was founded in 2015 and is headquartered in San Francisco, California.